MARKET

YMAB

Y-Mabs Therapeutics
YMAB
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-12.8661
4.417
4.472
391,224,796.20
HBM Healthcare Investments Reports CHF 236 Million Quarterly Profit, NAV Up 16.4%
Reuters · 10/01 15:49
Y-Mabs Therapeutics Completes Merger with Perseus BidCo
TipRanks · 09/16 13:20
Y-mAbs Therapeutics Inc. Completes Merger with Perseus BidCo US, Inc., Becoming Wholly Owned Subsidiary
Reuters · 09/16 12:59
Weekly Report: what happened at YMAB last week (0908-0912)?
Weekly Report · 09/15 09:07
Weekly Report: what happened at YMAB last week (0901-0905)?
Weekly Report · 09/08 09:07
Y-Mabs Therapeutics’ Phase 2 Trial: A Potential Breakthrough for Neuroblastoma Treatment
TipRanks · 09/07 16:32
Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?
NASDAQ · 09/01 13:55
Weekly Report: what happened at YMAB last week (0825-0829)?
Weekly Report · 09/01 09:06
More

Webull offers Y-Mabs Therapeutics stock information, including NASDAQ: YMAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, YMAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading YMAB stock methods without spending real money on the virtual paper trading platform.